Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Cancer Genomics and Diagnostics, and Neuroendocrine Tumor Research Advances.
Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
An Antibiotic Stewardship Program in Pancreatic Surgery
Expert Judgment Supporting a Bayesian Network to Model the Survival of Pancreatic Cancer Patients
European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals
Nationwide cost-effectiveness and quality of life analysis of minimally invasive distal pancreatectomy
Evaluation of five nutritional scores as predictors of postoperative outcome following pancreatic resection: A prospective, single-center study
Evaluation of five nutritional scores as predictors of postoperative outcome in pancreatic surgery: A prospective, single-center study
Antibiotic stewardship program in pancreatic surgery: a multicenter, before-after analysis.
Neutralization of NET-associated human ARG1 enhances cancer immunotherapy
A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer
Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: A retrospective, multicenter analysis
Treatment characteristics and outcomes of pure Acinar cell carcinoma of the pancreas – A multicentric European study on radically resected patients
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis
Distal Pancreatectomy Fistula Risk Score (D-FRS)
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis
Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract